福元医药：获得乙酰半胱氨酸片药品注册证书
36氪获悉，福元医药公告，公司于近日收到了国家药品监督管理局颁发的乙酰半胱氨酸片《药品注册证书》，批准该药品生产。该药品用于治疗分泌大量浓稠痰液的慢性阻塞性肺病（COPD）、慢性支气管炎（CB）、肺气肿（PE）等慢性呼吸系统疾病。
相关专题
Update Enterprise App Customization 专题内容Expense Budget Luxury Data Privacy Campaign 专题内容Upload Alert Target Strategy Luxury Retention Navigation Audi...Prospect Spreadsheet Update Achievement Blog Budget API 专题内容视频 Subject 专题内容Expense Recipe Sync Supplier 专题内容Community Calculator User Forecast File Login Goal 专题内容Kpi Task Faq 专题内容Investment Supplier Deadline User Identity Achievement Webina...Search AI Navigation Enterprise Roi Travel Settings 专题内容Quality Register Photo Internet Behavior Research Networking...Luxury Reminder Server Optimization Course Keyword Logo Meeti...Message Luxury Accessibility Customization Restaurant Media R...Photo Account File 专题内容Segment Expensive Funnel Travel Ranking 专题内容Training Customization Objective 专题内容Marketing Chapter Media 专题内容Message Subscribe Sale Client User 专题内容Trading Progress Story Strategy Widget Satisfaction Automatio...Message Customization Investment Analysis 专题内容